Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04808245
Title A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas (INTERCEPT-H3)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors German Cancer Research Center
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.